- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 vaccines and myocarditis
Authors
Keywords
-
Journal
CLINICAL MEDICINE
Volume 23, Issue 5, Pages 495-502
Publisher
Royal College of Physicians
Online
2023-09-29
DOI
10.7861/clinmed.2023-0049
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
- (2023) Bertrand Moal et al. PLoS One
- Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
- (2022) Emma K. Accorsi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
- (2022) Matthew E. Oster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The role of cardiovascular magnetic resonance in the evaluation of acute myocarditis and inflammatory cardiomyopathies in clinical practice — a comprehensive review
- (2022) Tevfik F Ismail et al. European Heart Journal-Cardiovascular Imaging
- Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
- (2022) Laura D. Zambrano et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
- (2022) Mark G. Thompson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021
- (2022) Amelia G. Johnson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- CMR Imaging 6 Months After Myocarditis Associated with the BNT162b2 mRNA COVID-19 Vaccine
- (2022) Gabriel Amir et al. PEDIATRIC CARDIOLOGY
- Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine–associated Myocarditis
- (2022) Matteo Fronza et al. RADIOLOGY
- Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
- (2022) S. Kristen Sexson Tejtel et al. VACCINE
- Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature
- (2022) Samantha Lane et al. BMJ Open
- Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong
- (2022) Xue Li et al. JAMA Pediatrics
- SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
- (2022) Øystein Karlstad et al. JAMA Cardiology
- Cardiac Adverse Events after Vaccination—A Systematic Review
- (2022) Kanak Parmar et al. Vaccines
- Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
- (2022) Walter Straus et al. CLINICAL INFECTIOUS DISEASES
- Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines
- (2022) Stéphane Le Vu et al. Nature Communications
- Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review
- (2022) Jennifer Pillay et al. BMJ-British Medical Journal
- Post–COVID-19 Symptoms and Conditions Among Children and Adolescents — United States, March 1, 2020–January 31, 2022
- (2022) Lyudmyla Kompaniyets et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
- (2022) Evelyn Twentyman et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Clinical Characteristics of Patients with Myocarditis following COVID-19 mRNA Vaccination: A Systematic Review and Meta-Analysis
- (2022) Reem H. Matar et al. Journal of Clinical Medicine
- Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada
- (2022) Sarah A. Buchan et al. JAMA Network Open
- Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
- (2022) Bettina Heidecker et al. EUROPEAN JOURNAL OF HEART FAILURE
- IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination
- (2022) Lorenz Thurner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study
- (2022) Ian Kracalik et al. Lancet Child & Adolescent Health
- Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination
- (2022) Constantin Schwab et al. Clinical Research in Cardiology
- Fulminant Myocarditis and Acute Appendicitis after COVID-19 Vaccination
- (2022) Hiroaki Kawano et al. INTERNAL MEDICINE
- Myopericarditis After COVID-19 mRNA Vaccination Among Adolescents and Young Adults
- (2022) Jun Yasuhara et al. JAMA Pediatrics
- Clinically suspected lethal viral myocarditis combined with encephalitis: a COVID‐19 vaccine complication
- (2022) Junhui Chen et al. ESC Heart Failure
- BNT162b vaccines protect rhesus macaques from SARS-CoV-2
- (2021) Annette B. Vogel et al. NATURE
- Epidemiological Impact of Myocarditis
- (2021) Ainoosh Golpour et al. Journal of Clinical Medicine
- Myocarditis With COVID-19 mRNA Vaccines
- (2021) Biykem Bozkurt et al. CIRCULATION
- Myocarditis After BNT162b2 and mRNA-1273 Vaccination
- (2021) Kathryn F. Larson et al. CIRCULATION
- Acute myocarditis: aetiology, diagnosis and management
- (2021) Temi Lampejo et al. CLINICAL MEDICINE
- Myocarditis and Pericarditis After Vaccination for COVID-19
- (2021) George A. Diaz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
- (2021) Julia W. Gargano et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
- (2021) Audrey Dionne et al. JAMA Cardiology
- Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
- (2021) Amanda B. Payne et al. JAMA Network Open
- Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
- (2021) Martina Patone et al. NATURE MEDICINE
- Myocarditis after Covid-19 Vaccination in a Large Health Care Organization
- (2021) Guy Witberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
- (2021) Dror Mevorach et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study
- (2021) Anders Husby et al. BMJ-British Medical Journal
- Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older
- (2021) Anthony Simone et al. JAMA Internal Medicine
- COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
- (2020) Raul D. Mitrani et al. HEART RHYTHM
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
- (2020) Gregory A. Roth et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started